SENSEX
NIFTY
GOLD
USD/INR

Weather

image 27    C

Health & Fitness News

The Economic Times

Health & Fitness / The Economic Times

details

Zydus Saroglitazar meets primary goal in global Phase II(b) MASH trial

Zydus Lifesciences said its drug Saroglitazar Magnesium met the primary goal of a global Phase II(b) trial for MASH, a serious liver disease linked to metabolic disorders.

31 Aug 2026 1:00 pm